Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of NBI-98854 in Healthy Subjects
Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
The purposes of this study are to: learn about the safety of the study drug (NBI-98854);
learn how subjects tolerate the study drug; and evaluate and compare the pharmacokinetics (PK
testing, the study of how the body absorbs, distributes, breaks down and eliminates a drug)
of the investigational study drug after taking it alone and with ketoconazole. Ketoconazole
is known to affect the PK of many drugs and is studied to more safely prescribe medications.